Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

177.50p
   
  • Change Today:
    -0.25p
  • 52 Week High: 706.00
  • 52 Week Low: 167.25
  • Currency: UK Pounds
  • Shares Issued: 4.34m
  • Volume: 879
  • Market Cap: £7.71m
  • RiskGrade: 340
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £333,215
Vladislav Sandler Ph.D. 103,862 £184,355
Peter Redmond 13,991 £24,834

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £333,215
Dr Vladislav Sandler 103,862 £184,355
Optiva Securities Limited 70,329 £124,834
Flascherberg Capital Anstalt 69,991 £124,234
Craig Auringer 59,593 £105,778
HSBC Client Holdings Nominee (UK) Limited 45,160 £80,159
Ron Valk 42,828 £76,020
Samantha Bauer 42,706 £75,803
Plum Capital 29,232 £51,887
43 North LLC 28,429 £50,462
Abdelatif LACHAB 6,500 £11,538
Wayne Gibson 6,500 £11,538

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 177.50p
Change Today -0.25p
% Change -0.14 %
52 Week High 706.00
52 Week Low 167.25
Volume 879
Shares Issued 4.34m
Market Cap £7.71m
Beta 0.00
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.73% below the market average48.73% below the market average48.73% below the market average48.73% below the market average48.73% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Price Trend
93.61% below the market average93.61% below the market average93.61% below the market average93.61% below the market average93.61% below the market average
78.72% below the sector average78.72% below the sector average78.72% below the sector average78.72% below the sector average78.72% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 20-May-2025

Time Volume / Share Price
08:07 50 @ 179.60p
08:02 829 @ 179.60p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page